Erratum: Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya (PLoS ONE (2014) 9:10 (e109353) doi:10.1371/journal.pone.0109353);Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vermandere, Heleen ^a   Naanyu, Violet ^b   Mabeya, Hillary ^b   Broeck, Davy Vanden ^a   Michielsen, Kristien ^a   Degomme, Olivier ^a  

^a GHENT UNIVERSITY   (Belgium)

^b MOI UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DRUG UPTAKE; FEMALE; HEALTH PROGRAM; HUMAN; KENYA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; QUESTIONNAIRE; SCHOOL CHILD; SEXUAL BEHAVIOR; SOCIAL ACCEPTANCE; UTERINE CERVIX CANCER; VACCINATION; WOMEN'S HEALTH; YOUNG ADULT; ATTITUDE TO HEALTH; IMMUNOLOGY; MALE; PAPILLOMAVIRUS INFECTIONS; PARENT; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; PROCEDURES; PSYCHOLOGY; SCHOOL; STUDENT; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; CHILD; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; KENYA; LONGITUDINAL STUDIES; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SCHOOLS; STUDENTS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84907821802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117761     Document Type: Erratum

References (54)

1. Globocan (2012) Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-population.aspx.
2. Louie KS, de Sanjose S, Mayaud P (2009) Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: A comprehensive review. Tropical Medicine & International Health 14: 1287-1302.
3. Anorlu R (2008) Cervical cancer: The sub-Saharan African perspective. Reproductive Health Matters 16: 41-49.
4. WHO (2009) Human papillomavirus vaccines WHO position paper. 15: 117- 132.
5. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
6. The Future II Study Group (2007) Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. The New England Journal of Medicine 256: 1915-1927.
7. Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM (2011) Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. International Journal of Cancer 128: 927-935.
8. Bingham A (2009) An Approach to Formative Research in HPV Vaccine Introduction Planning in Low-Resource Settings. The Open Vaccine Journal.
9. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS (2010) HPV vaccine acceptability among Kenyan women. Vaccine 28: 4864-4867.
10. Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, et al. (2012) Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS One 7: e40766.
11. Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, et al. (2008) Determinants of Human Papillomavirus Vaccine Acceptability in Latin America and the Caribbean. Vaccine 26: L73-L79.
12. Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL (2009) Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 27: 1668-1673.
13. Young A (2010) HPV vaccine acceptance among women in the Asian Pacific: A systematic review of the literature. Asian Pac J Cancer Prev 11: 641-649.
14. Hopkins TG, Wood N (2013) Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 31: 1673-1679.
15. Watson M, Shaw D, Molchanoff L, McInnes C (2009) Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Australian and New Zealand journal of public health 33: 365-370.
16. Coleman MA, Levison J, Sangi-Haghpeykar H (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29: 3945-3950.
17. Perlman S, Wamai RG, Bain PA, Welty T, Welty E, et al. (2014) Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: A systematic review. PLoS One 9: e90912.
18. Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, et al. (2008) An assessment of the readiness for introduction of the HPV vaccine in Uganda. African journal of reproductive health 12: 159-172.
19. Harries J (2009) Preparing for HPV vaccination in South Africa: Key challenges and opinions. Vaccine 27: 38-44.
20. Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, et al. (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28: 8026-8032.
21. Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, et al. (2011) A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 29: 8760- 8765.
22. Iliyasu Z, Abubakar IS, Aliyu MH, Galadanci HS (2010) Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. Journal of obstetrics and gynaecology: The journal of the Institute of Obstetrics and Gynaecology 30: 857- 862.
23. DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT (2011) A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS One 6: e25481.
24. Remes P, Selestine V, Changalucha J, Ross DA, Wight D, et al. (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 30: 5363-5367.
25. Ugwu EO, Obi SN, Ezechukwu PC, Okafor, II, Ugwu AO (2013) Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria. Nigerian journal of clinical practice 16: 249-252.
26. Morhason-Bello IO, Adesina OA, Adedokun BO, Awolude O, Okolo CA, et al. (2013) Knowledge of the human papilloma virus vaccines, and opinions of gynaecologists on its implementation in Nigeria. African journal of reproductive health 17: 150-156.
27. Poole DN, Tracy JK, Levitz L, Rochas M, Sangare K, et al. (2013) A crosssectional study to assess HPV knowledge and HPV vaccine acceptability in Mali. PLoS One 8: e56402.
28. Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, et al. (2012) Awareness, acceptability and uptake of human papilloma virus vaccine among Cameroonian school-attending female adolescents. Journal of community health 37: 1127-1135.
29. Bingham A (2009) Sociocultural Issues in the Introduction of Human Papillomavirus Vaccine in Low-Resource Settings.
30. Marlow LA (2011) HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes. Br J Cancer 105: 486-492.
31. Constantine NA, Jerman P (2007) Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health 40: 108-115.
32. Hendry M, Lewis R, Clements A, Damery S, Wilkinson C (2013) "HPV? Never heard of it!": A systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine 31: 5152- 5167.
33. Wigle J, Coast E, Watson-Jones D (2013) Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine 31: 3811-3817.
34. Brabin L, Greenberg D, Hessel L, Hyer R, Ivanoff B, et al. (2008) Current issues in adolescent immunization. Vaccine 26: 4120-4134.
35. Cover JK, Nghi NQ, Lamontagne DS, Huyen DT, Hien NT, et al. (2012) Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: An in-depth qualitative study post-vaccination. BMC Public Health 12: 629.
36. Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, et al. (2012) Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: A case control study. PLoS One 7: e45231.
37. Galagan SR, Paul P, Menezes L, LaMontagne DS (2013) Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine 31: 3072-3078.
38. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, et al. (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in lowand middle-income countries. Bull World Health Organ 89: 821B-830B.
39. Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J (2014) Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health 14: 670.
40. Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, et al. (2012) Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 12: 370.
41. Moodley I, Tathiah N, Mubaiwa V, Denny L (2013) High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 103: 318-321.
42. Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, et al. (2012) Human Papillomavirus Vaccination in Tanzanian Schoolgirls: Cluster-Randomized Trial Comparing 2 Vaccine-Delivery Strategies. J Infect Dis 206: 678- 686.
43. Babirye JN, Rutebemberwa E, Kiguli J, Wamani H, Nuwaha F, et al. (2011) More support for mothers: A qualitative study on factors affecting immunisation behaviour in Kampala, Uganda. BMC Public Health 11: 723.
44. Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the Reasons Why Mothers Do or Do Not Have Their Adolescent Daughters Vaccinated Against Human Papillomavirus. Annals of Epidemiology 19: 531- 538.
45. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, et al. (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of women's health (2002) 18: 1679-1686.
46. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, et al. (2011) Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 38: 197-204.
47. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, et al. (2012) Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 90: 623-628.
48. Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, et al. (2013) Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health 103: 1419-1427.
49. Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW (2013) Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Prev Med 10.1016/j.ypmed.2013.05.013.
50. Paul P, Fabio A (2014) Literature review of HPV vaccine delivery strategies: Considerations for school- And non-school based immunization program. Vaccine 32: 320-326.
51. Gerend MA, Shepherd MA, Shepherd JE (2013) The multidimensional nature of perceived barriers: global versus practical barriers to HPV vaccination. Health psychology: official journal of the Division of Health Psychology, American Psychological Association 32: 361-369.
52. Hertweck SP, LaJoie AS, Pinto MD, Flamini L, Lynch T, et al. (2013) Health care decision making by mothers for their adolescent daughters regarding the quadrivalent HPV vaccine. J Pediatr Adolesc Gynecol 26: 96-101.
53. Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, et al. (2012) Human papillomavirus vaccination intentions and uptake in college women. Health psychology: official journal of the Division of Health Psychology, American Psychological Association 31: 685-693.
54. Grabenstein JD (2013) What the world's religions teach, applied to vaccines and immune globulins. Vaccine 31: 2011-2023.